Trinity Biotech (NASDAQ:TRIB) Now Covered by Analysts at StockNews.com
Analysts at StockNews.com initiated coverage on shares of Trinity Biotech (NASDAQ:TRIB – Get Free Report) in a note issued to investors on Thursday. The firm set a “sell” rating on the stock. Trinity Biotech Trading Down 2.1 % Shares of TRIB opened at $0.78 on Thursday. Trinity Biotech has a 12 month low of $0.48 […]
